The Real Cost of a Prior Authorization Denial Isn't the Denial

When a claim denies for lack of authorization, the immediate reaction is usually to route it to the denial team for appeal. That's the correct next step — but it's also the point where the real cost of the problem has already been paid, and it wasn't primarily a billing cost.

The bigger cost is upstream: a scheduled procedure that had to be cancelled or rescheduled because authorization wasn't confirmed in time. For a surgical case, that's OR time that goes unfilled, a patient whose care is delayed, and a provider whose day is restructured on short notice. None of that shows up on a denial report, because the claim in question may never have been submitted at all.

This is why authorization-related denial rate is a misleading metric in isolation. A program can show a low denial rate simply because problematic cases get caught and cancelled before a claim is ever generated — which looks clean on a billing report and terrible on an operational one.

The organizations that actually solve this measure a different number: authorization confirmation lead time relative to the scheduled date of service. When that lead time is short or negative — authorization still pending as the appointment approaches — that's the leading indicator that predicts both denials and cancellations, days or weeks before either happens.

Solving it requires authorization tracking to start at the moment of scheduling, not as a pre-visit checklist item the week before. It requires escalation paths that treat an approaching date of service as urgent on its own, independent of whether a denial has technically occurred yet. And it requires patient access and scheduling teams to see authorization status as their problem, not something to hand off to billing once it's already gone wrong.